BioSpace News Archive

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on our Probody® therapeutic technology platform, announced today that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in the following virtual healthcare conferences in September.

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present at Baird’s 2020 Virtual Global Healthcare Conference on Wednesday, September 9, 2020 at 10:50 a.m. ET.

Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), today announced that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation to MB-107, Mustang’s lentiviral gene therapy for the treatment of X-linked severe combined immunodeficiency (“XSCID”), also known as bubble boy disease

MyoKardia, Inc. (Nasdaq: MYOK) today announced its participation in the following upcoming investor conferences: Citi’s 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020. Taylor Harris, Chief Financial Officer, will participate in a fireside chat at 4:15 p.m. EDT. Wells Fargo 2020 Virtual Healthcare Conference on Thursday, September 10, 2020. Tassos Gianakakos, Chief Executive Officer, will participate in a fir

WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, announced this morning that Jodie N. Heggelund will serve as the company’s Global President of Spine & Biologics, effective immediately.

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that the Company will release its 2020 fiscal year end financial results after the close of the U.S. financial markets on September 9, 2020. The Company will host a conference call and live webcast wi

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that its Board of Directors has approved a share repurchase program of up to 1 million ordinary shares on the open market or otherwise

MetricStream, the independent market leader in enterprise cloud applications for Governance, Risk, and Compliance (GRC)/Integrated Risk Management, today announced that the company has been positioned as a Leader in the 2020 Gartner Magic Quadrant for IT Vendor Risk Management Tools.

Transparency Market Research has published a new report titled, “Radiation Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Transparency Market Research has published a new report on the life science reagents market for the forecast period of 2019–2027.